Enanta Pharma (NASDAQ:ENTA) announced its Q4 earnings on Monday, November 25, 2024 at 04:01 PM.
Here's a breakdown of the earnings report.
Earnings
Enanta Pharma beat estimated earnings by 4.0%, reporting an EPS of $-1.36 versus an estimate of $-1.41.
Revenue was down $4.33 million from the same period last year.
Performance in Previous Earnings
During the previous quarter, the company beat on EPS by $0.38, leading to a 1.0% increase share price change the next day.
Here's a look at Enanta Pharma's past performance:
| Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| EPS Estimate | -1.45 | -1.33 | -1.19 | -2 |
| EPS Actual | -1.07 | -1.47 | -1.58 | -1.33 |
| Revenue Estimate | 17.18M | 16.52M | 21.28M | 17.50M |
| Revenue Actual | 17.97M | 17.05M | 18.00M | 18.93M |
To track all earnings releases for Enanta Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
